標(biāo)題: Titlebook: Biotechnology and Pharmacy; John M. Pezzuto (Professor and Interim Head, Assoc Book 1993 Springer Science+Business Media Dordrecht 1993 DN [打印本頁] 作者: Addendum 時間: 2025-3-21 17:24
書目名稱Biotechnology and Pharmacy影響因子(影響力)
書目名稱Biotechnology and Pharmacy影響因子(影響力)學(xué)科排名
書目名稱Biotechnology and Pharmacy網(wǎng)絡(luò)公開度
書目名稱Biotechnology and Pharmacy網(wǎng)絡(luò)公開度學(xué)科排名
書目名稱Biotechnology and Pharmacy被引頻次
書目名稱Biotechnology and Pharmacy被引頻次學(xué)科排名
書目名稱Biotechnology and Pharmacy年度引用
書目名稱Biotechnology and Pharmacy年度引用學(xué)科排名
書目名稱Biotechnology and Pharmacy讀者反饋
書目名稱Biotechnology and Pharmacy讀者反饋學(xué)科排名
作者: 秘密會議 時間: 2025-3-21 22:06 作者: lipids 時間: 2025-3-22 03:41 作者: MOAN 時間: 2025-3-22 05:15 作者: MOAT 時間: 2025-3-22 09:03
The Impact of Biotechnology on Analytical Methodologyteins, hormones (including an increasing number of cell growth factors), and carrier or transport proteins. Second are the poly- and oligonucleotides, the primary information carriers of molecular biology. From a pharmaceutical point of view they are the “reagents” needed to produce the proteins and作者: Enteropathic 時間: 2025-3-22 15:30
Drug Delivery Aspects of Biotechnology Productsbiological response modifiers function in the body. It is now possible, through the use of recombinant DNA techniques or by solid phase protein synthesis, to produce on a commercial scale a large variety of regulatory agents that are therapeutically applicable. The list of these response modifiers i作者: EWE 時間: 2025-3-22 18:27
Applications of Recombinant DNA Technology to the Diagnosis of Genetic Disease: Molecular Methods fo inappropriate expression or the nonexpression of a functional gene product, or in the production of a nonfunctional gene product. The mutations can be of various categories, ranging from point mutations or small insertions or deletions that are not cytologically detectable, to grosser abnormalities作者: forthy 時間: 2025-3-22 22:17
Human Genome Mapping and Sequencing: Applications in Pharmaceutical Sciencehments are reviewed and discussed elsewhere in this volume. Some of the most notable successes have come in preventing or treating diseases of bacterial or viral etiology. In this context the relatively recent increased incidence of AIDS (acquired immunodeficiency syndrome) and viral hepatitis (caus作者: 協(xié)迫 時間: 2025-3-23 03:24
Clinical Use of Monoclonal Antibodies diagnostic imaging and therapy. Although the early studies focused primarily on cancer, the field has branched out to include most major forms of human disease. The early optimism that the clinical arena would be quickly conquered has been tempered by reality. Although some MAbs have demonstrated c作者: 庇護(hù) 時間: 2025-3-23 07:31 作者: 造反,叛亂 時間: 2025-3-23 09:45 作者: 使迷醉 時間: 2025-3-23 14:45 作者: 低能兒 時間: 2025-3-23 19:49 作者: 吵鬧 時間: 2025-3-23 23:57 作者: Bouquet 時間: 2025-3-24 03:26 作者: –FER 時間: 2025-3-24 08:31 作者: 新義 時間: 2025-3-24 14:41
John M. Pezzuto (Professor and Interim Head, Assoc作者: 無聊點好 時間: 2025-3-24 15:38
Lebensstil und Umgehen mit Umweltn the typical heterocyclic organic chemicals. More recently this technology has been recognized as a powerful tool for facilitating more classical pharmaceutical and drug development efforts. The reader is, however, referred to the other chapters for more detailed examples, especially of pharmaceuti作者: 公社 時間: 2025-3-24 21:34
https://doi.org/10.1007/978-3-8350-9650-9es, can be indicative of the differentiation and clonal status of various hematological malignancies. The diagnosis of these diseases, or the determination of carrier status for recessive heritable disorders, can thus be approached by analyzing DNA.作者: Magnificent 時間: 2025-3-25 02:15 作者: DUST 時間: 2025-3-25 04:58
Lebensstil und Umgehen mit Umweltable to large–scale fermentation and produce high yields within short periods. In fact, after some 15 years worth of effort there are a number of patents that have been issued describing plant tissue culture systems that yield various compounds.; in general, however, such systems have proven less su作者: CERE 時間: 2025-3-25 10:59
https://doi.org/10.1007/978-3-322-99689-3s rate of growth in biotechnology product sales would result in an $11 billion industry by the year 2000. These predictions arise from the tremendous increased growth in biotechnology research. Over the past 4 years the number of biotechnology medicines in development has grown by 63%.. The United S作者: Exaggerate 時間: 2025-3-25 13:58
Background to Recombinant DNA Technologyn the typical heterocyclic organic chemicals. More recently this technology has been recognized as a powerful tool for facilitating more classical pharmaceutical and drug development efforts. The reader is, however, referred to the other chapters for more detailed examples, especially of pharmaceuti作者: Mercurial 時間: 2025-3-25 17:28
Applications of Recombinant DNA Technology to the Diagnosis of Genetic Disease: Molecular Methods foes, can be indicative of the differentiation and clonal status of various hematological malignancies. The diagnosis of these diseases, or the determination of carrier status for recessive heritable disorders, can thus be approached by analyzing DNA.作者: 推崇 時間: 2025-3-25 21:24
Oral Adenoviruses as the Carriers for Human Immunodeficiency Virus or Hepatitis B Virus Surface Anti vaccine development because they exhibit several characteristics that allow for high expression of foreign viral genes. In this chapter several features of the adenovirus vector system as applied to its use for vaccination purposes will be reviewed, with an emphasis on the use of adenoviruses as va作者: CARE 時間: 2025-3-26 01:30
The Use of Nonclassical Techniques in the Production of Secondary Metabolites by Plant Tissue Culturable to large–scale fermentation and produce high yields within short periods. In fact, after some 15 years worth of effort there are a number of patents that have been issued describing plant tissue culture systems that yield various compounds.; in general, however, such systems have proven less su作者: 材料等 時間: 2025-3-26 06:55
Biotechnology Products: An Overviews rate of growth in biotechnology product sales would result in an $11 billion industry by the year 2000. These predictions arise from the tremendous increased growth in biotechnology research. Over the past 4 years the number of biotechnology medicines in development has grown by 63%.. The United S作者: 染色體 時間: 2025-3-26 09:15
Lebensstil und Umgehen mit Umwelte already aware of its value. It will emphasize terminology and provide general descriptions of the procedures, with a primary focus on why molecular biology is having such an impact (some call it a revolution) on biological studies. The chapter will also include a few scientific examples, since it 作者: debacle 時間: 2025-3-26 13:22 作者: FLAGR 時間: 2025-3-26 18:20
,Sozialisation, Identit?t und Lebensstil,y these cells. These factors produced by the cells of the immune system are referred to as cytokines in the generic sense. More specifically, factors produced by lymphocytes are known as lymphokines, whereas those produced by macrophages are known as monokines. Recent progress in biotechnology is ba作者: 高度表 時間: 2025-3-26 21:36 作者: 秘傳 時間: 2025-3-27 02:36
https://doi.org/10.1007/978-3-8350-9650-9teins, hormones (including an increasing number of cell growth factors), and carrier or transport proteins. Second are the poly- and oligonucleotides, the primary information carriers of molecular biology. From a pharmaceutical point of view they are the “reagents” needed to produce the proteins and作者: 調(diào)味品 時間: 2025-3-27 07:53
Zusammenfassung: Theorie und Hypothesen,biological response modifiers function in the body. It is now possible, through the use of recombinant DNA techniques or by solid phase protein synthesis, to produce on a commercial scale a large variety of regulatory agents that are therapeutically applicable. The list of these response modifiers i作者: Distribution 時間: 2025-3-27 10:10
https://doi.org/10.1007/978-3-8350-9650-9 inappropriate expression or the nonexpression of a functional gene product, or in the production of a nonfunctional gene product. The mutations can be of various categories, ranging from point mutations or small insertions or deletions that are not cytologically detectable, to grosser abnormalities作者: modifier 時間: 2025-3-27 16:44 作者: extinguish 時間: 2025-3-27 21:29 作者: enumaerate 時間: 2025-3-28 01:44
https://doi.org/10.1007/978-3-8350-9650-9s to be resistant to all forms of curative therapy. After it was established that AIDS was caused by an RNA virus, many research groups rushed to find agents that would inhibit in vitro multiplication of the virus. One approach that was followed was the random screening of a wide variety of nucleosi作者: 跟隨 時間: 2025-3-28 05:12 作者: macrophage 時間: 2025-3-28 06:25 作者: CALL 時間: 2025-3-28 12:26 作者: 我沒有強迫 時間: 2025-3-28 17:15 作者: 胖人手藝好 時間: 2025-3-28 19:21
https://doi.org/10.1007/978-3-322-99689-3aceutical drug development, the history of biotechnology is relatively short. A chronological review was recently reported by the Ernst & Young High Technology Group.. Currently there are approximately 1,100 biotechnology companies nationwide (public, private, and subsidiary) employing an estimated 作者: transdermal 時間: 2025-3-29 00:37
Individualisierung und Lebensstilbildungenregardless of the practice setting. Changes in the drug product have necessitated increased pharmacy participation in patient care. Biotechnology will dictate drug therapy in the future; therefore, it is critical for pharmacists to become familiar with these products as well as their impact on patie作者: Hearten 時間: 2025-3-29 05:32 作者: Senescent 時間: 2025-3-29 08:02
https://doi.org/10.1007/978-94-015-8135-6DNA; biology; biotechnology; chemistry; drug delivery; drug development; drug discovery; genome; pharmaceuti作者: AV-node 時間: 2025-3-29 13:00 作者: trigger 時間: 2025-3-29 15:45 作者: 露天歷史劇 時間: 2025-3-29 23:17 作者: 迎合 時間: 2025-3-30 02:39
https://doi.org/10.1007/978-3-8350-9650-9ited these animal RTs were available, these agents were tested against the RT of HIV-1. A third approach was the random screening of already available chemical substances. Indeed, a combination of these approaches did provide the initial drug leads in the early years of the epidemic.作者: Incorruptible 時間: 2025-3-30 04:20
https://doi.org/10.1007/978-3-322-99689-3ves defining the structural and conformational characteristics of the active region of large-molecular-weight drugs and then producing relatively small molecular weight structural analogues that are anticipated to mediate similar biological responses (see Chapter 14, this volume).作者: Optimum 時間: 2025-3-30 09:37
The Impact of Biotechnology on Analytical Methodologypolysaccharides are now recognized to have additional functions. Last, there are cells and organisms that have been genetically altered. As with all new pharmaceutical products, new products derived through biotechnology require characterization.作者: 巨大沒有 時間: 2025-3-30 13:07
Clinical Use of Monoclonal Antibodies to conjugate other molecules to MAbs, and the biochemical and physiological complexities of the diseases being tackled. Major advances have now been made in many of these areas, and it is likely that the next decade will witness the fulfillment of much of the early promise concerning the clinical use of MAbs.作者: 不妥協(xié) 時間: 2025-3-30 17:58
